Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Study of Photodynamic Therapy (PDT) With Metvix® 160 mg/g Cream in Immuno-compromised Patients With Non-melanoma Skin Cancer

NCT00472459 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT00472459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00472459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Study of Photodynamic Therapy (PDT) With Metvix® 160 mg/g Cream in Immuno-compromised Patients With Non-melanoma Skin Cancer
Lead sponsor
Galderma R&D
Phase
Phase 3
Overall status
Completed
Start date
July 25, 2003
Completion date
July 14, 2006
Enrollment
82 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis, basal cell carcinoma, bowens disease, squamous cell carcinoma, warts